EX-FILING FEES 7 d346782dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107.1

CALCULATION OF REGISTRATION FEE

Form S-3

(Form Type)

Centessa Pharmaceuticals plc

(Exact name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
    

Security

Type

 

Security

Class

Title

  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered(2)
  Proposed
Maximum
Offering
Price Per
Share (3)
 

Maximum
Aggregate

Offering

Price

  Fee Rate  

Amount of
Registration

Fee

  Carry
Forward  
Form
Type
  Carry
Forward  
File
Number
  Carry
Forward  
Initial
effective
date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities
                         

Fees to Be

Paid

  Equity(1)   Ordinary shares, nominal value £0.002 per share(3)(2)   Rule 457(o)                    
                         
    Other   American Depositary Shares   Rule 457(o), Rule 457(k)                    
                         
    Debt   Debt Securities(2)   Rule 456(o)                    
                         
    Other   Warrants(2)   Rule 456(o)                    
                         
    Other   Units(2)   Rule 457(o)                    
                         
   

Unallocated

(Universal) Shelf

 

Unallocated

(Universal) Shelf

  Rule 457(o)       $350,000,000     $0.0000927     $32,445.00            
                         
Fees Previously Paid                          
 
Carry Forward Securities
                         

Carry

Forward Securities

                       
                   
    Total Offering Amounts      $350,000,000     $32,445.00          
                   
    Total Fees Previously Paid                   
                   
    Total Fee Offsets                   
                   
    Net Fee Due                $32,445.00                

 

(1)

The amount to be registered consists of up to $350,000,000 of an indeterminate amount of ordinary shares, debt securities, warrants and/or units that may be offered and sold from time to time in one or more offerings. The ordinary shares may be represented by American Depositary Shares (“ADSs”), each of which currently represents one ordinary share. A separate registration statement on Form F-6 has been or will be filed for the registration of ADSs issuable upon deposit of the ordinary shares. The proposed maximum initial offering price per unit will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder as to each class of security. The securities registered also include such indeterminate number of ordinary shares represented by ADSs and the amount of debt securities as may be issued upon conversion of or exchange for debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the anti-dilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act, the ordinary shares, including ADSs representing ordinary shares, being registered hereunder include such indeterminate number of shares and ADSs representing ordinary shares as may be issuable with respect to the shares being registered hereunder as a result of share splits, share dividends or similar transactions.

(2)

Such indeterminate number or amount of ordinary shares, debt securities, warrants and/or units to purchase any combination of the foregoing securities, as may from time to time be issued at indeterminate prices, and units composed of one or more of the foregoing securities, with an aggregate initial offering price not to exceed $350,000,000. Securities registered hereunder may be sold separately or together in any combination with other securities registered hereunder. Warrants may be exercised to purchase any of the other securities registered hereby. The securities registered hereunder also include such indeterminate number of ordinary shares and amount of debt securities as may be issued upon conversion of or exchange for securities that provide for conversion or exchange, upon exercise of securities or pursuant to the antidilution provisions of any other securities.

(3)

The proposed maximum offering price per security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to Instruction 2.A(iii)(b) of Item 16(b) of Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”).